Khiron Life Sciences Corp.
KHRNH.V
TSX
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 2.59M | 3.50M | 3.67M | 2.89M | 2.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.59M | 3.50M | 3.67M | 2.89M | 2.79M |
| Cost of Revenue | 1.33M | 1.66M | 2.49M | 1.96M | 1.35M |
| Gross Profit | 1.27M | 1.84M | 1.18M | 928.80K | 1.44M |
| SG&A Expenses | 3.79M | 3.80M | 4.71M | 5.21M | 4.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.28M | 5.95M | 7.63M | 7.46M | 6.45M |
| Operating Income | -2.69M | -2.44M | -3.97M | -4.57M | -3.66M |
| Income Before Tax | -2.65M | -1.73M | -4.28M | -15.83M | -2.65M |
| Income Tax Expenses | 95.80K | -27.40K | -4.70K | -358.60K | 800.00 |
| Earnings from Continuing Operations | -2.74M | -1.70M | -4.27M | -15.47M | -2.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.74M | -1.70M | -4.27M | -15.47M | -2.65M |
| EBIT | -2.69M | -2.44M | -3.97M | -4.57M | -3.66M |
| EBITDA | -2.42M | -2.11M | -3.64M | -4.46M | -3.38M |
| EPS Basic | -0.01 | -0.01 | -0.02 | -0.09 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted | -0.02 | -0.01 | -0.02 | -0.09 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 214.53M | 186.44M | 179.40M | 179.00M | 177.03M |
| Average Diluted Shares Outstanding | 214.53M | 186.44M | 179.40M | 179.00M | 177.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
